title: American Diabetes Association recommendations on haemoglobin A1c use in diabetes diagnosis: time to include point-of-care devices?
authors.affiliation: 3U Diabetes, Department of Diabetes and Endocrinology, Royal College of Surgeons in Ireland, Connolly Hospital, Dublin, Ireland seamus.sreenan@hse.ie.
authors.forename: Seamus
authors.initials: S
authors.lastname: Sreenan
authors.affiliation: Department of Chemical Pathology, Connolly Hospital, Dublin and Biomedical Sciences, University of Ulster, Coleraine, Northern Ireland.
authors.forename: William
authors.initials: W
authors.lastname: Tormey
mesh_terms: D003920:Diabetes Mellitus / Q000097:blood / Q000175:diagnosis*; D006442:Glycated Hemoglobin / Q000378:metabolism*; D006452:Hemoglobinometry; D006801:Humans; D019095:Point-of-Care Systems; D017410:Practice Guidelines as Topic
chemical_list: D006442:Glycated Hemoglobin; C517652:hemoglobin A1c protein, human